Overall, these findings show that ERK3 expression is linked to the expression of key partial-EMT markers in breast and pancreatic cancer—SNAIL, KRT14, and YAP—and it regulates the expression of protumour proteins such as β-catenin and CYR61 in a cancer type-dependent manner. This evidence concerns the gene MAPK6 and familial pancreatic carcinoma.